Clinical Trials Logo

Acne Vulgaris clinical trials

View clinical trials related to Acne Vulgaris.

Filter by:

NCT ID: NCT00706433 Completed - Acne Vulgaris Clinical Trials

Light Dose Ranging Study of Photodynamic Therapy (PDT) With Levulan + Blue Light Versus Vehicle + Blue Light in Severe Facial Acne

Start date: March 2007
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine and compare the safety and efficacy of multiple broad area photodynamic therapy treatments with aminolevulinic acid (ALA-PDT) and vehicle (VEH-PDT) in subjects with moderate to severe facial acne vulgaris.

NCT ID: NCT00696449 Completed - Acne Vulgaris Clinical Trials

Analysis of Adherence in Subjects Undergoing Differin Gel, 0.1% Treatment of Moderate to Severe Acne Vulgaris

Start date: June 2006
Phase: Phase 4
Study type: Interventional

The primary objective of this study is to investigate potential differences between four treatment intervention groups in the adherence to treatment with Differin® Gel, 0.1%. Differin is approved by the Food and Drug Administration (FDA) to treat acne.

NCT ID: NCT00689117 Completed - Acne Vulgaris Clinical Trials

A Clinical Study to Evaluate the Safety and Effectiveness of an Investigational Product Called CT Gel

Start date: April 2008
Phase: Phase 3
Study type: Interventional

The purpose of this study is to demonstrate the safety and effectiveness of CT Gel in subjects with acne vulgaris. The hypothesis is that CT Gel is superior to Clindamycin Gel, Tretinoin Gel and Vehicle Gel for the treatment of acne vulgaris.

NCT ID: NCT00688064 Completed - Clinical trials for Severe Acne Vulgaris

Adapalene-BPO Gel Associated With Doxycycline Hyclate 100 mg in the Treatment of Severe Acne Vulgaris

ACCESS I
Start date: August 2008
Phase: Phase 3
Study type: Interventional

The purpose of this study is to demonstrate the efficacy of Adapalene 0.1% / Benzoyl Peroxide (quoted as BPO) 2.5% Gel associated with Doxycycline Hyclate 100 mg Tablets compared to Adapalene 0.1% /Benzoyl Peroxide 2.5% Vehicle Gel associated with Doxycycline Hyclate 100 mg Tablets, in the treatment of severe acne vulgaris. The safety of the two treatment regimens will also be evaluated.

NCT ID: NCT00687908 Completed - Acne Clinical Trials

Adapalene-Benzoy Peroxide (BPO) Gel in the Treatment of Acne Vulgaris as a 6-month Maintenance

ACCESS II
Start date: November 2008
Phase: Phase 3
Study type: Interventional

The purpose of this study is to demonstrate the efficacy of Adapalene 0.1% /Benzoyl Peroxide 2.5% Gel compared to its Vehicle Gel as an acne maintenance treatment in Subjects previously treated with Adapalene-BPO Gel or Adapalene-BPO Vehicle Gel both associated with Doxycycline Hyclate 100 mg. The safety of the two investigational treatments will also be assessed.

NCT ID: NCT00673933 Completed - Acne Vulgaris Clinical Trials

Photodynamic Therapy (PDT) With Methyl Aminolevulinate (MAL) Cream in Patients With Skin Type V or IV With Acne Vulgaris

Start date: May 2008
Phase: Phase 2
Study type: Interventional

In this multicenter study, patients with dark skin and acne vulgaris will be included. The patients will receive treatment with MAL PDT and placebo PDT.

NCT ID: NCT00671749 Completed - Acne Vulgaris Clinical Trials

Combination Therapy With Differin® Gel 0.3% and Duac® (Clindamycin/Benzoyl Peroxide Gel) in Subjects With Acne Vulgaris

Start date: December 2007
Phase: Phase 4
Study type: Interventional

This study is to determine the efficacy and safety of 12 week treatment with Differin® Gel 0.3% applied in the evening, in combination with Duac® (Clindamycin/Benzoyl Peroxide Gel) applied in the morning, in Subjects with Acne vulgaris.

NCT ID: NCT00666900 Completed - Acne Vulgaris Clinical Trials

A Clinical Study Evaluating the Safety and Efficacy of IDP-107 in Patients With Acne Vulgaris

Start date: January 2008
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the safety and effectiveness of IDP-107 in treating patients with acne vulgaris.

NCT ID: NCT00664248 Completed - Acne Vulgaris Clinical Trials

A Clinical Study Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris

Start date: October 2006
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess the effectiveness of IDP-110 in treating patients with acne vulgaris.

NCT ID: NCT00663286 Completed - Acne Vulgaris Clinical Trials

A Clinical Trial Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris

Start date: October 2006
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess the effectiveness of IDP-110 in treating patients with acne vulgaris.